VRTX Company Profile and Key Details
Vertex Pharmaceuticals Incorporated
VRTX Stock Price Chart
Stock Price Today
Vertex Pharmaceuticals Incorporated (VRTX) stock surged +2.53%, trading at $482.28 on NASDAQ, up from the previous close of $470.37. The stock opened at $468.04, fluctuating between $467.35 and $482.74 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAFTA for the treatment of patients with CF 6 years of age or older who have at least one F508del mutation. Its pipeline includes VX-864 for the treatment of AAT deficiency, which is in Phase 2 clinical trial; VX-147 for the treatment of APOL1-mediated focal segmental glomerulosclerosis, or FSGS, and other serious kidney diseases which is in Phase 2 clinical trial; VX- 880, treatment for Type 1 Diabetes which is in Phase 1/2 clinical trial; VX-548, a NaV1.8 inhibitor for treatments of acute, neuropathic, musculoskeletal pain which is in Phase 2 clinical trial; and CTX001 for the treatment severe SCD and TDT which is in Phase 3 clinical trial. The company sells its products primarily to specialty pharmacy and specialty distributors in the United States, as well as specialty distributors and retail chains, and hospitals and clinics internationally. It has collaborations with Affinia Therapeutics, Inc.; Arbor Biotechnologies, Inc.; CRISPR Therapeutics AG.; Kymera Therapeutics, Inc.; Mammoth Biosciences, Inc.; Moderna, Inc.; Obsidian Therapeutics, Inc.; and Skyhawk Therapeutics, Inc.; as well as Ribometrix, Inc.; Genomics plc; Merck KGaA; Darmstadt, Germany, and X-Chem, Inc. Vertex Pharmaceuticals Incorporated was founded in 1989 and is headquartered in Boston, Massachusetts.
Company Information
| Employees | 5400 |
| Beta | 0.39 |
| Sales or Revenue | $9.84B |
| 5Y Sales Change% | 2.196% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) stock price is $482.28 in the last trading session. During the trading session, VRTX stock reached the peak price of $482.74 while $467.35 was the lowest point it dropped to. The percentage change in VRTX stock occurred in the recent session was 2.53% while the dollar amount for the price change in VRTX stock was $11.91.
The NASDAQ listed VRTX is part of Biotechnology industry that operates in the broader Healthcare sector. Vertex Pharmaceuticals Incorporated designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Damian W. Wilmot Esq.
Senior Vice President, Chief Risk and Compliance Officer
Dr. Jeffrey Marc Leiden M.D., Ph.D.
Executive Chairman
Dr. Ourania Tatsis Ph.D.
Executive Vice President and Chief Regulatory & Quality Officer
Susie Lisa
Senior Vice President of Investor Relations
Ms. Kristen C. Ambrose
Chief Accounting Officer & SVice President of Accounting, Tax, Treasury, Strategic Sourcing & Corporation Services
Mr. Stuart A. Arbuckle B.Sc.
Executive Vice President & Chief Operating Officer
Mr. Mike Tirozzi
SVice President and Chief Information & Data Officer
Dr. Reshma Kewalramani FASN, M.D.
Chief Executive Officer, Pres & Director
Mr. Charles F. Wagner Jr.
Executive Vice President & Chief Financial Officer
Dr. David M. Altshuler M.D., Ph.D.
Executive Vice President of Global Research & Chief Scientific Officer
Mr. Jonathan Biller J.D.
Executive Vice President & Chief Legal Officer
VRTX's closing price is 27.64% higher than its 52-week low of $377.85 where as its distance from 52-week high of $519.88 is -7.23%.
Number of VRTX employees currently stands at 5,400.
Official Website of VRTX is: https://www.vrtx.com
VRTX could be contacted at phone 617 341 6100 and can also be accessed through its website. VRTX operates from 50 Northern Avenue, Boston, MA 02210, United States.
VRTX stock volume for the day was 1.95M shares. The average number of VRTX shares traded daily for last 3 months was 1.65M.
The market value of VRTX currently stands at $124.20B with its latest stock price at $482.28 and 257.53M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com